InsiderPulseNo transactions found.
No financial data available for PIRS.
Company may not file with SEC or CIK is unresolved.
Pieris Pharma surges on all-stock merger deal
Pieris Pharmaceuticals OKs 1-for-80 reverse stock split
Pieris gains on milestone payment from Boston Pharma
Pieris sinks 60% as AstraZeneca halts mid-stage trial for Asthma candidate
Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites
Pieris Pharmaceuticals, Inc. (PIRS) Q1 2023 Earnings Call Transcript
Pieris Pharmaceuticals Q1 2023 Earnings Preview
Notable earnings before Wednesday's open